Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients
Clinical trial NCT02048865 · COMPLETED
Trial details
- NCT number
- NCT02048865
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-24
- Primary completion
- 2018-10-10
- Enrollment
- 575
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.